Prior to the BPCA, many medications prescribed to children were not specifically tested for pediatric use, leading to potential issues with dosage, efficacy, and safety. The BPCA was implemented to address these gaps in pediatric drug research, ensuring that children receive medications that are both safe and effective for their unique physiological needs.
